Fig. 3
A Kaplan-Meier survival analysis for OS in Group 1,2 and 3 according to the new predictive model in the validation cohort. B Kaplan-Meier survival analysis for OS in Group 1,2 and 3 for patients at high-risk in the validation cohort
Fig. 3 | BMC Cancer